Fresenius Medical Care announces acquisition of Hema Metrics assets related to Crit-Line system

Fresenius Medical Care AG & Co. KGaA ("the company" or "Fresenius Medical Care"), the world's largest provider of dialysis products and services, today announced the acquisition of all assets of Hema Metrics LLC related to its Crit-Line^® system. Based on its strong dialysis product business and sales organization, Fresenius Medical Care intends to establish this technology as the standard of care for fluid and anemia management in the North American market. The Crit-Line^® system is an excellent fit with Fresenius Medical Care North America's 2008K, 2008K2, and 2008T hemodialysis machines.

The Crit-Line^® system enables noninvasive optical measurement of absolute blood parameters such as percent blood volume change, absolute hematocrit level and continuous oxygen saturation. The Crit-Line^® system is an effective tool for the clinician to improve fluid management with less clinical complications, such as hypotension. Improved fluid management may lead to fewer hospitalizations for renal patients. Accurate hematocrit measurement, real time, provides the clinician immediate feedback, supporting anemia management. The Crit-Line^® system and its associated products are FDA 510(k) cleared, and carry the CE mark.